Venous thromboembolism (VTE) is regarded as the most preventable cause of inpatient death in hospital settings globally. VTE can be prevented through the provision of non-pharmacological and/or pharmacological thromboprophylaxis following individualised risk screening. The Caprini risk assessment model (RAM) offers a validated and well-established approach for VTE risk assessment in medical inpatients. Literature findings describe a trend towards inappropriate and under-prescribing of thromboprophylaxis in this population. Together with concerns regarding clinicians’ perceived importance of VTE risk assessment, the need to clarify these aspects of practice is evident. To describe VTE risk assessment and prophylaxis practices of medical prac...
BACKGROUND: Information about the variation in the risk for venous thromboembolism (VTE) and in prop...
Aim: The aim is to assess risk and evaluate the usage of pharmacological thromboprophylaxis adhering...
Background: Venous thromboembolism (VTE) is a major public health challenge globally due to its high...
Magister Pharmaceuticae - MPharmBackground: Venous thromboembolism (VTE) is reported to be the leadi...
Background. Venous thromboembolism (VTE) is a common complication during and after hospitalisation, ...
Background. Venous thromboembolism (VTE) is a common complication during and after hospitalisation, ...
Background. The TUNE-IN (The Use of VTE prophylaxis in relatioN to patiEnt risk profiling) study eva...
Background. The TUNEIN (The Use of VTE prophylaxis in relatioN to patiEnt risk profiling) study eval...
Introduction: venous thromboembolism is a complication among admitted medical and surgical patients....
Background. Patients in acute hospital care show a high risk for venous thromboembolism (VTE); 52% o...
Background: Prophylactic venous thromboembolism (VTE) strategies have the greatest impact on patient...
387-394Information about the variation in the risk for venous thromboembolism (VTE) and in prophylax...
Limited data are available regarding the risk for venous thromboembolism (VTE) and VTE prophylaxis u...
Limited data are available regarding the risk for venous thromboembolism (VIE) and VIE prophylaxis u...
Deep vein thrombosis and pulmonary embolism are significant reasons of chronic illness & death in pe...
BACKGROUND: Information about the variation in the risk for venous thromboembolism (VTE) and in prop...
Aim: The aim is to assess risk and evaluate the usage of pharmacological thromboprophylaxis adhering...
Background: Venous thromboembolism (VTE) is a major public health challenge globally due to its high...
Magister Pharmaceuticae - MPharmBackground: Venous thromboembolism (VTE) is reported to be the leadi...
Background. Venous thromboembolism (VTE) is a common complication during and after hospitalisation, ...
Background. Venous thromboembolism (VTE) is a common complication during and after hospitalisation, ...
Background. The TUNE-IN (The Use of VTE prophylaxis in relatioN to patiEnt risk profiling) study eva...
Background. The TUNEIN (The Use of VTE prophylaxis in relatioN to patiEnt risk profiling) study eval...
Introduction: venous thromboembolism is a complication among admitted medical and surgical patients....
Background. Patients in acute hospital care show a high risk for venous thromboembolism (VTE); 52% o...
Background: Prophylactic venous thromboembolism (VTE) strategies have the greatest impact on patient...
387-394Information about the variation in the risk for venous thromboembolism (VTE) and in prophylax...
Limited data are available regarding the risk for venous thromboembolism (VTE) and VTE prophylaxis u...
Limited data are available regarding the risk for venous thromboembolism (VIE) and VIE prophylaxis u...
Deep vein thrombosis and pulmonary embolism are significant reasons of chronic illness & death in pe...
BACKGROUND: Information about the variation in the risk for venous thromboembolism (VTE) and in prop...
Aim: The aim is to assess risk and evaluate the usage of pharmacological thromboprophylaxis adhering...
Background: Venous thromboembolism (VTE) is a major public health challenge globally due to its high...